The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma

Targeted Inhibition of Multiple Receptor Tyrosine Kinases in Mesothelioma

(2015) Wen-Bin Ou et al.   NEOPLASIA

Molecular Changes in Mesothelioma With an Impact on Prognosis and Treatment

(2012) Didier Jean et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Validation of Prognostic Factors in Malignant Pleural Mesothelioma: A Retrospective Analysis of Data from Patients Seeking Compensation from the New South Wales Dust Diseases Board

(2012) Steven C. Kao et al.   Clinical Lung Cancer

Axl is essential for VEGF-A-dependent activation of PI3K/Akt

(2012) Guo-Xiang Ruan et al.   EMBO JOURNAL

Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma

(2012) David James Pinato et al.   Journal of Thoracic Oncology

Plasma Cell Membrane Localization of c-MET Predicts Longer Survival in Patients with Malignant Mesothelioma: A Series of 157 Cases from the MESOPATH Group

(2012) Guénaëlle Levallet et al.   Journal of Thoracic Oncology

Exploratory analysis of activation of PTEN–PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)

(2012) S. Cedrés et al.   LUNG CANCER

Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: A harmful procedure

(2012) Ottavio Rena et al.   LUNG CANCER

Biomarkers for Malignant Pleural Mesothelioma

(2012) Laurent Greillier et al.   Molecular Diagnosis & Therapy

Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma

(2011) Clint E. Johnson et al.   BREAST CANCER RESEARCH AND TREATMENT

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

(2011) Tom Treasure et al.   LANCET ONCOLOGY

Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma

(2010) Xianzhou Song et al.   CANCER

High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy

(2010) S. C. H. Kao et al.   CLINICAL CANCER RESEARCH

Outcome for Patients with Malignant Pleural Mesothelioma Referred for Trimodality Therapy in Western Australia

(2010) Arman Hasani et al.   Journal of Thoracic Oncology

AXL regulates mesothelioma proliferation and invasiveness

(2010) W-B Ou et al.   ONCOGENE

Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer

(2010) K Vuoriluoto et al.   ONCOGENE

Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6

(2009) S. Loges et al.   BLOOD

Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival

(2009) C. Gjerdrum et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Prostatic Intraepithelial Neoplasia-Dependent p27Kip1 Checkpoint Induces Senescence and Inhibits Cell Proliferation and Cancer Progression

(2008) Pradip K. Majumder et al.   CANCER CELL

Axl and Growth Arrest Specific Gene 6 Are Frequently Overexpressed in Human Gliomas and Predict Poor Prognosis in Patients with Glioblastoma Multiforme

(2008) M. Hutterer et al.   CLINICAL CANCER RESEARCH